Global IT Research

World Brought to you

Sebia sFLC Assay – Defining a New Standard of Excellence in Serum Free Light Chain Testing

Sebia sFLC Assay – Defining a New Standard of Excellence in Serum Free Light Chain Testing

 

sebia-s-flc-assay-defining-a-new-standard-of-excellence-in-serum-free-light-chain-testing

Sebia sFLC Assay: A New Standard in Free Light Chain Testing

More accurate. Less repeat testing. Truly lab-friendly.
Sebia’s sFLC (Serum Free Light Chain) assay offers a powerful solution for diagnosing and monitoring monoclonal gammopathies like multiple myeloma and AL amyloidosis. Built on ELISA technology, it eliminates key limitations seen in legacy nephelometric or turbidimetric methods—delivering clinically actionable results with fewer false positives and negatives.

Accurate results. Confident decisions. Reduced cost and complexity.
Sebia’s sFLC assay is redefining what’s possible in light chain testing. From increased analytical reliability to broad lab compatibility, it’s the trusted choice for modern hematology diagnostics.

Download the brochure or contact Sebia to discuss validation on your platform.

White Paper from  sebia_logo Brought to you by: sebia_logo

    Read the full content

     


    You have been directed to this site by Global IT Research. For more details on our information practices, please see our Privacy Policy, and by accessing this content you agree to our Terms of Use. You can unsubscribe at any time.

    If your Download does not start Automatically, Click Download Whitepaper

    Show More

    Related Articles